References - Optical Coherence Tomography in Age-related Macular Degenera

  1. Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical Coherence Tomography of the retina and the Optic Nerve. Clin Experiment Ophthalmol 2009;37:90-99.
     
  2. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 2007;144:627–37.
     
  3. Coscas F, Coscas G, Souied E, Tick S, Soubrane G. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007;144:592–599.
     
  4. Pieroni CG, Witkin AJ, Ko TH, Fujimoto JG, Chan A, Schuman JS, Ishikawa H, Reichel E, Duker JS.. Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration. Br J Ophthalmol 2006;90:191–197.
     
  5. Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217–229.
     
  6. Brancato R, Tremoloada G. Tomografia óptica de coherencia en la degeneración macular asociada a la edad. En: Monés J, Gómez-Ulla F. Degeneración macular asociada a la edad. Proas Science 2005;73-84.
     
  7. Criado Muñoz P. Tomografía de Coherencia Óptica en el estudio de la patología macular. Boletín de la Sociedad Oftalmologica de Madrid - N.º 48, 2008.
     
  8. España Contreras M, Fernández-Baca Casares I. OCT en las enfermedades retinianas y del nervio óptico. E.U.R.O.M.E.D.I.C.E., Ediciones Médicas, S. L. 2007;15-30.
     
  9. Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B, Ahlers C, Sattmann H, Scholda C, Fercher AF, Drexler W.. Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 2005;46:3393-3402.
     
  10. Sunness JS, Margalit E, Srikumaran D, Applegate CA, Tian Y, Perry D, Hawkins BS, Bressler NM.. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology 2007;114:271-277.
     
  11. Chen TC, Cense B, Miller JW, Rubin PA, Deschler DG, Gragoudas ES, de Boer JF. Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol 2006;141:1165-8.
     
  12. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report nº 6. Am J Ophthalmol 2001;132:668–681.
     
  13. Hageman GS, Luthert PJ, Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20:705-732.
     
  14. Yi K, Mujat M, Park BH, Sun W, Miller JW, Seddon JM, Young LH, de Boer JF, Chen TC. Spectral Domain Optical Coherence Tomography for quantitative evaluation of  drusen and associated structural changes in non-neovascular age-related macular degeneration. Br J Ophthalmol 2009;93:176-81.
     
  15. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 2008;115:1883-90.
     
  16. Sandhu SS, Talks SJ. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Br J Ophthalmol 2005;89:967-970.
     
  17. Bearelly S, Chau FY, Koreishi A, Stinnett SS, Izatt JA, Toth CA. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology 2009;116(9):1762-9.
     
  18. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007;114:253-62.
     
  19. Liakopoulos S, Ongchin S, Bansal A, Msutta S, Walsh AC, Updike PG, Sadda SR. Quantitative Optical Coherence Tomography findings in varios subtypes of Neovascular Age-related Macular Degeneration. Invest Ophthalmol Vis Sci 2008;49:5048-54.
     
  20. Hughes EH, Khan J, Patel N, Kashani S, Chong NV. In vivo demonstration of the anatomic differences between classic and occult choroidal neovascularization using optical coherence tomography. Am J Ophthalmol 2005;139:344-346.
     
  21. Hee MR, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR, Coker JG, Schuman JS, Swanson EA, Fujimoto JG. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-1270.
     
  22. Keane PA, Liakopoulos S, Chang KT, Wang M, Dustin L, Walsh AC, Sadda SR. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 2008;115:2206-14.
     
  23. Sadda SR, Liakopoulos S, Keane PA, Ongchin SC, Msutta S, Chang KT, Walsh AC. Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions. Graefes Arch Clin Exp Ophthalmol 2009;247(8):1031-7.
     
  24. Iijima H, Iida T, Imai M, Gohdo T, Tsukahara S. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2000;129:21–26.
     
  25. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008;28(9):1265-9.
     
  26. Okubo A, Sameshima M, Uemura A, Kanda S, Ohba N. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002;86:1093–1098.
     
  27. Ozawa S, Ishikawa K, Ito Y, Nishihara H, Yamakoshi T, Hatta Y, Terasaki H. Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by optical coherence tomography. Retina 2009;29:793-802.
     
  28. Gross NE, Aizman A, Brucker A, Klancnik JM Jr, Yannuzzi LA. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 2005;25:713-718.
     
  29. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-434.
     
  30. Brancato R, Introini U, Pierro L, Setaccioli M, Forti M, Bolognesi G, Tremolada G. Optical coherence tomography (OCT) in retinal angiomatous proliferation (RAP). Eur J Ophthalmol 2002;12:467-72.
     
  31. Chen TC, Cense B, Pierce MC, Nassif N, Park BH, Yun SH, White BR, Bouma BE, Tearney GJ, de Boer JF. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 2005;123:1715-20.
     
  32. Han IC, Jaffe GJ. Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes. Am J Ophthalmol 2009;147:847-58.
     
  33. Mylonas G, Ahlers C, Malamos P, Golbaz I, Deak G, Schuetze C, Sacu S, Schmidt-Erfurth U. Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration.  Br J Ophthalmol 2009;93:1453-60.
     
  34. Patel PJ, Chen FK, da Cruz L, Tufail A. Segmentation error in Stratus optical coherence tomography for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:399-404.
     
  35. Ghazi NG, Kirk T, Allam S, Yan G. Quantification of error in optical coherence tomography central macular thickness measurement in wet age-related macular degeneration. Am J Ophthalmol 2009;148:90-6.
     
  36. Krebs I, Falkner-Radler C, Hagen S, Haas P, Brannath W, Lie S, Ansari-Shahrezaei S, Binder S. Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. Invest Ophthalmol Vis Sci 2009;50:995-1000.
     
  37. Sayanagi K, Sharma S, Yamamoto T, Kaiser PK. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology 2009;116:947-55.
     
  38. Krebs I, Ansari-Shahrezaei S, Goll A, Binder S. Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2008;246:811-5.
     
  39. Malamos P, Sacu S, Georgopoulos M, Kiss C, Pruente C, Schmidt-Erfurth U. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Invest Ophthalmol Vis Sci 2009;50:4926-33.
     
  40. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496-500.
     
  41. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147:644-52.
     
  42. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-5.
     
  43. Salinas-Alamán A, García-Layana A, Maldonado MJ, Sainz-Gómez C, Alvárez-Vidal A. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. Am J Ophthalmol 2005;140:23-8.
     
  44. van Velthoven ME, de Smet MD, Schlingemann RO, Magnani M, Verbraak FD. Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT. Graefes Arch Clin Exp Ophthalmol 2006;244:1119-23.
     
  45. Talks J, Koshy Z, Chatzinikolas K. Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration. Br J Ophthalmol 2007;91:600-1.
     
  46. Brar M, Kozak I, Cheng L, Bartsch DU, Yuson R, Nigam N, Oster SF, Mojana F, Freeman WR. Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol 2009;148:439-44.
     
  47. Stopa M, Bower BA, Davies E, Izatt JA, Toth CA. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina 2008;28:298-308.
     
  48. Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology 2009;116:488-496.
     
  49. Lujan BJ, Rosenfeld PJ, Gregori G, Wang F, Knighton RW, Feuer WJ, Puliafito CA. Spectral domain optical coherence tomographic imaging of geographic atrophy. Ophthalmic Surg Lasers Imaging 2009;40:96-101.
     
  50. Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007;144:850-857.
     
  51. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T,; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 2009;116:57-65.
     
  52. Kaiser PK, Blodi BA, Shapiro H, Acharya NR; MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-75.
     
  53. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-83.
     
  54. Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009;148:43-58.
     
  55. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 2008;145:239-248.
     
  56. Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A; EXCITE Study Group. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology 2011;118:831-9.
     
  57. Mitchell P, Korobelnik JF, Lanzetta P, Holz FG, Pruente C, Schmidt-Erfurth UM, Tano Y, Wolf S. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 2010;94(1):2-13.
     
  58. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. Am J Ophthalmol 2007;143:679-80.
     
  59. Regillo CD. Overview of Maintenance Phase Paradigms for Anti-VEGF Therapy for Wet AMD. Retina: The Cutting Edge. AAO 2009 Subspeciality Day, 23-24 October San Francisco, CA, USA. Section III, AMD Part III-Exudative AMD:40.
     
  60. Singh RP, Fu EX, Smith SD, Williams DR, Kaiser PK. Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study. Br J Ophthalmol 2009;93:1353-8.
     
  61. Kiss CG, Geitzenauer W, Simader C, Gregori G, Schmidt-Erfurth U. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function. Invest Ophthalmol Vis Sci 2009;50:2376-83.
     
  62. Sayanagi K, Sharma S, Kaiser PK. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 2009;93(5):622-6.
     
  63. Kaluzny JJ, Wojtkowski M, Sikorski BL, Szkulmowski M, Szkulmowska A, Bajraszewski T, Fujimoto JG, Duker JS, Schuman JS, Kowalczyk A. Analysis of the outer retina reconstructed by high-resolution, three-dimensional spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging 2009;40:102-8.
     
  64. Chen Y, Vuong LN, Liu J, Ho J, Srinivasan VJ, Gorczynska I, Witkin AJ, Duker JS, Schuman J, Fujimoto JG. Three-dimensional ultrahigh resolution optical coherence tomography imaging of age-related macular degeneration. Opt Express 2009;17:4046-60.
     
  65. Witkin AJ, Vuong LN, Srinivasan VJ, Gorczynska I, Reichel E, Baumal CR, Rogers AH, Schuman JS, Fujimoto JG, Duker JS. High-speed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmology 2009;116:956-63.
     
  66. Lee SJ, Lee CS, Koh HJ. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol 2009;147:621-626.
     
  67. Mojana F, Cheng L, Bartsch DU, Silva GA, Kozak I, Nigam N, Freeman WR. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol 2008;146:218-227.
     
  68. Ahlers C, Golbaz I, Einwallner E, Dunavölgyi R, Malamos P, Stock G, Pruente C, Schmidt-Erfurth U.  Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease. Invest Ophthalmol Vis Sci 2009;50:3417-24.
     
  69. Brinkmann CK, Wolf S, Wolf-Schnurrbusch UE. Multimodal imaging in macular diagnostics: combined OCT-SLO improves therapeutical monitoring. Graefes Arch Clin Exp Ophthalmol 2008;246:9-16.
     
  70. Wolf-Schnurrbusch UE, Enzmann V, Brinkmann CK, Wolf S. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci 2008;49:3095-9.
     
  71. Fleckenstein M, Charbel Issa P, Helb HM, Schmitz-Valckenberg S, Finger RP, Scholl HP, Loeffler KU, Holz FG. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:4137-44.
     
  72. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29:1469-73.
     
  73. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol  2009 ;147:801-10.
     
  74. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009;148:445-50.
     
  75. Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, Duker JS. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2005;112:1734-46.
     
  76. Gorczynska I, Srinivasan VJ, Vuong LN, Chen RW, Liu JJ, Reichel E, Wojtkowski M, Schuman JS, Duker JS, Fujimoto JG. Projection OCT fundus imaging for visualising outer retinal pathology in non-exudative age-related macular degeneration. Br J Ophthalmol 2009;93:603-9.
     
  77. Srinivasan VJ, Monson BK, Wojtkowski M, Bilonick RA, Gorczynska I, Chen R, Duker JS, Schuman JS, Fujimoto JG. Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 2008;49:1571-9.
     
  78. Heiferman M, Simonett J; Fawzi A. En Face OCT Imaging in Retinal Disorders An emerging technique offers innovative insights. Retinal Physician 2015;12:45-48, 50.
     
  79. Lau T, Wong IY, Iu L, Chhablani J, Yong T, Hideki K, Lee J, Wong R. En-face optical coherence tomography in the diagnosis and management of age-relate macular degeneration and polypoidal choroidal vasculopathy. Indian J Ophthalmol 2015;63:378-83.
  80. Nunes RP, Gregori G, Yehoshua Z, Stetson PF, Feuer W, Moshfeghi AA, Rosenfeld PJ. Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. Ophthalmic Surg Lasers Imaging Retina 2013;44:344-359.
     
  81. Flores-Moreno I, Arias-Barquet L, Rubio-Caso MJ, Ruiz-Moreno JM, Duker JS, Caminal JM. En face swept-source optical coherence tomography in neovascular age-related macular degeneration. Br J Ophthalmol 2015;99:1260-7.
     
  82. Sayanagi K, Gomi F, Akiba M, Sawa M, Hara C, Nishida K. En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy. Br J Ophthalmol 2015;99:29-35.
     
  83. Kokame GT, Shantha JG, Hirai K, Ayabe J. En Face Spectral-Domain Optical Coherence Tomography for the Diagnosis and Evaluation of Polypoidal Choroidal Vasculopathy. Ophthalmic Surg Lasers Imaging Retina 2016;47:737-44.
     
  84. Semoun O, Coscas F, Coscas G, Lalloum F, Srour M, Souied EH. En face enhanced depth imaging optical coherence tomography of polypoidal choroidal vasculopathy. Br J Ophthalmol 2016;100:1028-34.
     
  85. Alasil T, Ferrara D, Adhi M, Brewer E, Kraus MF, Baumal CR, Hornegger J, Fujimoto JG, Witkin AJ, Reichel E, Duker JS, Waheed NK.En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography. Am J Ophthalmol 2015;159:634-643.
     
  86. Grulkowski I, Liu JJ, Potsaid B, Jayaraman V, Lu CD, Jiang J, Cable AE, Duker JS, Fujimoto JG. Retinal, anterior segment and full eye imaging using ultrahigh speed swept source OCT with vertical-cavity surface emitting lasers. Biomed Opt Express 2012;3:2733-51.
     
  87. Ruiz-Medrano J, Flores-Moreno I, Peña-García P, Montero JA, García-Feijóo J, Duker JS, Ruiz-Moreno JM. Analysis of age-related choroidal layers thinning in healthy eyes using swept-source coherence tomography. Retina 2016 Oct [Epub ahead of print].
     
  88. Uzun S, Pehlivan E. Choroidal and Retinal Thickness in Children With Different Refractive Status Measured by Swept-Source Optical Coherence Tomography. Am J Ophthalmol 2016;169:298-9. 
     
  89. Maruko I, Arakawa H, Koizumi H, Izumi R, Sunagawa H, Iida T. Age-Dependent Morphologic Alterations in the Outer Retinal and Choroidal Thicknesses Using Swept Source Optical Coherence Tomography. PLoS One 2016;11(7):e0159439. 
     
  90. Kuroda Y, Ooto S, Yamashiro K, Oishi A, Nakanishi H, Tamura H, Ueda-Arakawa N, Yoshimura N. Increased Choroidal Vascularity in Central Serous Chorioretinopathy Quantified Using Swept-Source Optical Coherence Tomography. Am J Ophthalmol 2016;169:199-207.
     
  91. Govetto A, Sarraf D, Figueroa MS, Pierro L, Ippolito M, Risser G, Bandello F, Hubschman JP. Choroidal thickness in non-neovascular versus neovascular age-related macular degeneration: a fellow eye comparative study. Br J Ophthalmol 2016 Sep 1. pii: bjophthalmol-2016-309281 [Epub ahead of print].
     
  92. Koustenis A Jr, Harris A, Gross J, Januleviciene I, Shah A, Siesky B. Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research. Br J Ophthalmol 2016 Oct 4. pii: bjophthalmol-2016-309389 [Epub ahead of print].
     
  93. Brijesh T, Shorya A. Assessment of Choroidal Topographic Changes by Swept Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration. Am J Ophthalmol 2016;162:202-3.
     
  94. Choi W, Moult EM, Waheed NK, Adhi M, Lee B, Lu CD, de Carlo TE, Jayaraman V,Rosenfeld PJ, Duker JS, Fujimoto JG. Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy. Ophthalmology 2015;122:2532-44.
     
  95. Ghasemi Falavarjani K, Al-Sheikh M, Akil H, Sadda SR. Image artefacts in swept-source optical coherence tomography angiography. Br J Ophthalmol. 2016 Jul 20. pii: bjophthalmol-2016-309104 [Epub ahead of print].
     
  96. Novais EA, Adhi M, Moult EM, Louzada RN, Cole ED, Husvogt L, Lee B, Dang S, Regatieri CV, Witkin AJ, Baumal CR, Hornegger J, Jayaraman V, Fujimoto JG, Duker  JS, Waheed NK. Choroidal Neovascularization Analyzed on Ultrahigh-Speed Swept-Source Optical Coherence Tomography Angiography Compared to Spectral-Domain Optical Coherence Tomography Angiography. Am J Ophthalmol 2016;164:80-8.
     
  97. Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen CL, Durbin MK, An L, Stetson PF, Robbins G, Miller A, Zheng F, Rosenfeld PJ. Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration. Ophthalmology 2016;123:1309-19. 
     
  98. Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH. Optical Coherence Tomography Angiography versus Traditional Multimodal Imaging in Assessing the Activity of Exudative Age-Related Macular Degeneration: A New Diagnostic Challenge. Retina 2015;35:2219-28.
View PDF